Physician profile
Ankit Doshi
NPI 1447657820
$1,536.19
in general payments reported to CMS, 2019-2025
16 companies · $205 in 2025
The $205 reported for 2025 was more than what 76% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.49 · 2020: $58.99 · 2021: $14.66 · 2022: $152 · 2023: $401 · 2024: $672 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $264.39 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $229.02 | 2019-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $190.47 | 2023-2024 | Xarelto |
| Fisher & Paykel Healthcare INC | $151.61 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $121.36 | 2024 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.99 | 2023-2025 | Ofev |
| Merck Sharp & Dohme LLC | $91.75 | 2025 | Capvaxive, Gardasil 9 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.06 | 2024 | Xifaxan |
| Viiv Healthcare Company | $53.09 | 2023-2024 | Rukobia |
| Teva Pharmaceuticals USA, INC. | $51.35 | 2024 | Uzedy |
| Abbvie INC. | $41.10 | 2021-2024 | |
| Shionogi INC | $32.66 | 2024 | Fetroja |
| Insmed, INC. | $29.03 | 2025 | Arikayce |
| Exact Sciences Corporation | $28.74 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $23.60 | 2025 | Cardiomems |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $21.97 | 2023 | Rezzayo, Vabomere, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.